Evidence map›Paper›PMID 31799244›Full record

ArticleFrontiers in bioengineering and biotechnology2019

Treatment of Hepatocellular Carcinoma by Intratumoral Injection of

Jun Zhou, Pengcheng Hu, Zhan Si, Hui Tan, Lin Qiu, He Zhang, Zhequan Fu, Wujian Mao, Dengfeng Cheng, Hongcheng Shi

Open access · goldAbstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Jun ZhouDepartment of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Pengcheng HuDepartment of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Zhan SiDepartment of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Hui TanDepartment of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Lin QiuDepartment of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
He ZhangDepartment of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Zhequan FuDepartment of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Wujian MaoDepartment of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Dengfeng ChengDepartment of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Hongcheng ShiDepartment of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
The First Affiliated Hospital, Sun Yat-sen University · CNFudan University · CNSun Yat-sen University · CNShanghai Institute of Hematology · CNZhongshan Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

125IAA98 mAbangiogenesisapoptosisCD146hepatocellular carcinoma

Identifiers

PMID31799244
PMCPMC6868101
OpenAlexW2983188381

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.